
RIDGETECH INC
RDGTNASDAQTrading Snapshot
- Day Range
- $0.95 β $0.97
- 52-Week Range
- $0.67 β $760.50
- Volume
- $1.60B
- Avg Volume
- $1.22B
- Shares Outstanding
- 3.6M
- Next Earnings
- Oct 3, 2026
Fundamentals Snapshot
- Annual Revenue
- $132M
- Last Q Revenue
- $69M
- P/E Ratio
- 0.3
- P/S Ratio
- 0.0x
- EPS (TTM)
- $326.05
- Dividend Yield
- β
Why Investors Own RDGT
- βHigh-growth profile β revenue up +32.8% YoY with expanding US Equity exposure.
- βHealthy economics β 60% gross margin and 15% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About RIDGETECH INC
Ridgetech, Inc. operates as a wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. It operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. The company engages in offline and online wholesale distribution of pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products comprising consumable, seasonal, and promotional items. It also distributes other healthcare products, such as health food, cosmetics, and daily necessities. The company was formerly known as China Jo-Jo Drugstores, Inc. and changed its name to Ridgetech, Inc. in February 2024. Ridgetech, Inc. is headquartered in Hangzhou, China.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
RIDGETECH INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift RDGT price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
RIDGETECH INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.